← All trials
NCT04323462
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2020
- Primary completion
- Oct 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- Mar 26, 2020
- Last posted
- Mar 31, 2020
- Enrollment
- 326
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Postgraduate Institute of Medical Education and ResearchLead sponsor
- Postgraduate Institute of Medical Education and ResearchReponsible party - principal investigator
- All India Institute of Medical SciencesCollaborator
- Amrita Institute of Medical SciencesCollaborator
- P.D. Hinduja Hospital and Medical Research Centre, MumbaiCollaborator
- Institute of Post Graduate Medical Education & ResearchCollaborator
- Jawaharlal Nehru Medical CollegeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.